Pharma Times
DECEMBER 15, 2020
A new report launched by Takeda has found that just 17% of UK adults surveyed felt their perception of pharma had improved based on the industry's response to COVID-19
NY Times
DECEMBER 11, 2020
British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
DECEMBER 23, 2020
The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity.
pharmaphorum
DECEMBER 23, 2020
NHS leaders have written to the UK prime minister urging him to extend the Brexit transition period by a month to avoid plunging the healthcare service into chaos on 1 January. The letter, published today by the NHS Confederation – a membership organisation representing NHS leaders from all parts of the health service, outlines concerns about the impact a no-deal outcome will have on delivering care to patients amid winter pressures and a rapid rise in COVID-19 infections. “The failu
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
DECEMBER 17, 2020
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. There are ten patents protecting this drug. This drug…. The post New patent for Paratek Pharms drug NUZYRA appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Marketing Network
DECEMBER 29, 2020
2020 was a year defined by unexpected challenges – and related opportunity – for pharmaceutical marketers. The COVID-19 pandemic pushed the industry to experiment with new media, emerging technologies and innovative platforms to keep physicians, providers and patients informed, engaged and empowered. As telehealth appointments replaced office visits, webinars replaced in-person conferences and digital communication replaced reps in the field, what have we learned about how to create connec
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NY Times
DECEMBER 25, 2020
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.
Outsourcing Pharma
DECEMBER 8, 2020
An expert from the clinical research technology specialist discusses how trial teams can use real-world evidence to improve study inclusivity.
pharmaphorum
DECEMBER 2, 2020
Few companies embody the term ‘pharma giant’ as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart. Both in their mid-twenties, the two men set up what was initially a fine chemicals business in a Brooklyn factory, using a loan from Pfizer’s father as capital.
Pharma Mirror
DECEMBER 14, 2020
The future of pharmaceutical manufacturing is mobile. Advances in cloud computing and the onset of Industry 4.0 has led to the proliferation of mobile IT solutions for manufacturing, including pharmaceuticals. Particularly, mobile workstations and tablets are becoming staples of the pharmaceutical manufacturing workflow due to their cost-effectiveness, particularly in demanding environments like cleanrooms, where even modular fixed human-machine interfaces (HMIs) can be exorbitantly priced and c
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Eye on FDA
DECEMBER 10, 2020
Sometimes in the midst of events, perspective is elusive. Today the Food and Drug Administration will hold a meeting of the Vaccines and Related Biologics Advisory Committee (VRBAC) to consider the application for an Emergency Use Authorization (EUA) submitted by Pfizer/BioNTech for their investigative vaccine for COVID-19. Usually prior to an FDA Advisory Committee meeting where a product is being considered for approval, the posting of the FDA Reviewer comments is greatly anticipated for what
Pharma Times
DECEMBER 22, 2020
Rekambys plus Vocabria authorised to treat HIV-1 infections in adults who are virologically suppressed
NY Times
DECEMBER 15, 2020
The positive review likely ensures that the F.D.A. will grant emergency authorization for a second coronavirus vaccine this week for millions of Americans.
Outsourcing Pharma
DECEMBER 22, 2020
A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug development.
pharmaphorum
DECEMBER 24, 2020
The UK’s COVID-19 vaccination programme could get a speed boost, with the country’s drugs regulator expected to make a decision on a shot from Oxford University/AstraZeneca in the next few days. If the vaccine becomes available the UK will be able to step up its vaccination programme as large swathes of the country face draconian “Tier 4” restrictions due to the emergence of as more infectious variant.
Drug Patent Watch
DECEMBER 9, 2020
Annual Drug Patent Expirations for VYXEOS Vyxeos is a drug marketed by Celator Pharms and is included in one NDA. It is available from one supplier. There are eight patents…. The post New patent for Celator Pharms drug VYXEOS appeared first on DrugPatentWatch - Make Better Decisions.
Eye on FDA
DECEMBER 1, 2020
In my last posting on preparedness for a post-vaccination world I touched on some of the questions facing employers in general – policy questions that should be considered now for the eventualities of later. But digging a little deeper, there are also questions to consider with respect to support for ensuring access to vaccines by communities of color.
Pharma Times
DECEMBER 9, 2020
ZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma
NY Times
DECEMBER 15, 2020
The U.S., Britain, Canada and others are hedging their bets, reserving doses that far outnumber their populations, as many poorer nations struggle to secure enough.
Outsourcing Pharma
DECEMBER 23, 2020
Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.
pharmaphorum
DECEMBER 21, 2020
2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% of total M&A deal values. That said, there were still some interesting moves indicating new directions of travel for big pharma players – with most deals focused on specific drugs from biotechs, particularly in cancer (though we did get rumours of an AstraZeneca-Gilead merger , which would have been the
Drug Patent Watch
DECEMBER 30, 2020
Annual Drug Patent Expirations for INVELTYS Inveltys is a drug marketed by Kala Pharms Inc and is included in one NDA. There are eight patents protecting this drug. INVELTYS drug…. The post New patent for Kala Pharms drug INVELTYS appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Marketing Network
DECEMBER 7, 2020
Tune in now to listen to Darshan Talks Podcast, What a Clinical Trial Transparency Program Is (and Why You Need One). The post What a Clinical Trial Transparency Program Is (and Why You Need One) appeared first on Pharma Marketing Network.
Pharma Times
DECEMBER 22, 2020
Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis
NY Times
DECEMBER 8, 2020
The Oxford-AstraZeneca effort held great promise to help arrest the pandemic. But a series of miscues caused it to fall behind in the U.S.
Outsourcing Pharma
DECEMBER 16, 2020
The head of the CROâs Global Center of Excellence for Decentralized Clinical Trial Strategy outlines key developments in 2020, and keys to success in 2021.
pharmaphorum
DECEMBER 17, 2020
Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow. Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment. Medicines discovery innovators, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence to find new disease ‘drivers’ and candidate drugs for lung cancer.
Drug Patent Watch
DECEMBER 10, 2020
Annual Drug Patent Expirations for ARISTADA+INITIO+KIT Aristada Initio Kit is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Alkermes Inc drug ARISTADA INITIO KIT appeared first on DrugPatentWatch - Make Better Decisions.
Pharma in Brief
DECEMBER 3, 2020
As we have previously reported, the Minister of Health ( Minister ) approved the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 ( Interim Order for Drugs and Vaccines ) on September 16, 2020 and the Interim order respecting the importation and sale of medical devices for use in relation to COVID-19 ( Interim Order for Medical Devices ) on March 18, 2020. .
Pharma Times
DECEMBER 9, 2020
Meet the winners of the 2020 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards
NY Times
DECEMBER 17, 2020
Estados Unidos, el Reino Unido, Canadá y otros países hicieron pedidos de vacunas que superan con creces a sus poblaciones, mientras muchas naciones pobres luchan por asegurarse las dosis que necesitan.
Outsourcing Pharma
DECEMBER 21, 2020
A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.
pharmaphorum
DECEMBER 3, 2020
A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies. In new guidance, the health technology assessment (HTA) agency has recommended iRhythm’s Zio XT service for detecting abnormal heart rhythms – provided NHS organisations that deploy it collect evidence of its benefits.
Drug Patent Watch
DECEMBER 16, 2020
Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are twelve patents protecting…. The post New patent for Nalpropion drug CONTRAVE appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Marketing Network
DECEMBER 9, 2020
An extensive report by eMarketer, AI In Drug Discovery and Development , discusses how AI can speed up the drug discovery and development process while eliminating costs, how startups are taking first steps at utilizing AI’s power to streamline the process of bringing a drug to market, and current barriers preventing AI from its full potential in the drug making process.
Expert insights. Personalized for you.
158 
Let's personalize your content